Lausanne, Switzerland

Stephan Proennecke

This inventor holds 6 USPTO granted patents and 4 published patent applications and 1 EPO patent. Top assignees: Debiotech S.a., Universitât Bern. Active years: 2018-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Stephan Proennecke. Retrieved from https://idiyas.com/inventor/stephan-proennecke

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 6 

% Patents Active = 83.3

 

Average Co-Inventor Count = 3.6

ph-index = 2

Forward Citations = 41(Granted Patents)


Location History:

  • Lausanne, CH (2018 - 2022)
  • Gex, FR (2022)

Company Filing History:


Years Active: 2018-2024

Loading Chart...
Loading Chart...
6 patents (USPTO):Explore Patents

Title: The Innovations of Stephan Proennecke

Introduction

Stephan Proennecke is a notable inventor based in Lausanne, Switzerland. He has made significant contributions to the field of drug therapy management, holding a total of six patents. His work focuses on improving the efficiency and effectiveness of medication delivery systems.

Latest Patents

Among his latest patents is a system and method for improving drug therapy management. This invention provides a method and product that utilizes a processor unit to analyze data related to blood glucose measurements over a specified time period. It retrieves medication delivery parameters executed by a delivery device during that time and accesses memory data associated with the patient's Continuous Insulin Release (CIR). The system then determines modifications to the therapy based on the retrieved data, enhancing patient care and treatment outcomes.

Career Highlights

Stephan Proennecke has worked with several prominent organizations, including Debiotech S.A. and Universität Bern. His experience in these institutions has allowed him to develop innovative solutions that address critical healthcare challenges.

Collaborations

Throughout his career, Proennecke has collaborated with notable colleagues such as Frédéric Neftel and Stavroula Mougiakakou. These partnerships have contributed to the advancement of his research and the successful implementation of his inventions.

Conclusion

Stephan Proennecke's contributions to drug therapy management through his innovative patents demonstrate his commitment to improving healthcare technology. His work continues to influence the field and enhance patient treatment options.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…